Atara Biotherapeutics (NASDAQ:ATRA) Receives News Sentiment Rating of 0.25

·

·

Atara Biotherapeutics (NASDAQ:ATRA) Receives News Sentiment Rating of 0.25

Atara Biotherapeutics logo Media stories about Atara Biotherapeutics (NASDAQ:ATRA) have trended somewhat positive recently, according to Accern Sentiment Analysis.
See Original Article

Trump Tells Reporter to Be "Quiet"

A White House reporter called out questions as Trump posed for photographs with interns in the East Room. Asked if Attorney General Jeff Sessions
See Original Article

Trump's FDA Commissioner on Drug Prices, Regulations, Science

U.S. Food and Drug Administration Commissioner Scott Gottlieb spoke with Bloomberg News about drug pricing, new medicine and regulations.
See Original Article

America's Biggest Oil Port Wants to Be a Two-Way Street

The biggest U.S. oil-import hub wants to grab a piece of surging North American crude exports. Louisiana Offshore Oil Port, the only terminal along the
See Original Article

Tanzania Hands Mining Company $190 Billion Tax Bill

Tanzania just hit Acacia Mining Plc with a tax bill equal to almost two centuries worth of the gold producer's revenue. The government issued the
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.